In a new study published in Facial Plastic Surgery, it has been proposed that botulinum toxin can be used alongside septorhinoplasty procedures to help correct the appearance of a crooked nose.
Miss Priyanka Chadha, Miss Lara Watson and junior doctor Miss Shonnelly Novintan explore the muscle anatomy of the face and its importance in avoiding complications when administering toxin injections
Pharmaceutical company Galderma will be hosting a webinar in partnership with the Aesthetics journal this month.
Patients have been warned not to fly to Turkey to receive botulinum neurotoxin (BoNT) injections in their stomach for weight loss following almost 70 reported botulism cases.
Medical aesthetic company Evolus has announced that its neurotoxin Nuceiva has received approval for sale in Australia.
The Joint Council for Cosmetic Practitioners (JCCP) has announced a national survey looking into patients’ experiences of botulinum toxin complications in the UK.
Pharmaceutical company Galderma has released the results of its two phase III studies for its liquid formulation of botulinumtoxinA (relabotulinumtoxinA).
Aesthetic manufacturer Croma-Pharma has announced the national approval of its new botulinum toxin in the UK.
Aesthetic practitioner and dentist Dr Harry Singh has launched a new complications folder resource.
As of January 25, aesthetic manufacturer Croma-Pharma has confirmed completion of the decentralised procedure for its new botulinum toxin.
We bring you the most up-to-date information for the Aesthetics community across a variety of media, including; news, webinars, podcasts, the Journal, reports, interviews and more!
aesthetics Journal
The Aesthetics Journal is the leading monthly publication for the medical aesthetics specialty. It is peer reviewed and spans an incredible volume of topics. Become a member today to receive the monthly print and digital Journal.
0203 096 1228
2nd Floor, Regal House, 70 London Road
Twickenham TW1 3QS, United Kingdom
© 2023 Easyfairs UK Ltd | Registered in England No. 05067979
